34 results on '"Jessen, Bart"'
Search Results
2. The contribution of physicochemical properties to multiple in vitro cytotoxicity endpoints
3. Transient knock down of checkpoint kinase 1 in hematopoietic progenitors is linked to bone marrow toxicity
4. A high content screening assay for identifying lysosomotropic compounds
5. Cardiovascular differentiation of imatinib and bosutinib in the rat
6. Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells
7. Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion
8. Mechanistic Investigation of Imatinib-Induced Cardiac Toxicity and the Involvement of c-Abl Kinase
9. Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature
10. Corneal Neovascularization and Ocular Irritancy Responses in Dogs Following Topical Ocular Administration of an EP4-Prostaglandin E2 Agonist
11. Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells
12. Retinal and Peripheral Nerve Toxicity Induced by the Administration of a Pan-Cyclin Dependent Kinase (cdk) Inhibitor in Mice
13. Gastric and Pancreatic Lesions in Rats Treated with a Pan-CDK Inhibitor
14. Assessment of Hepatocytes and Liver Slices as in Vitro Test Systems to Predict in Vivo Gene Expression
15. Role of Sp1 Response Element in Transcription of the Human Transglutaminase 1 Gene
16. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model
17. Keratinocyte Differentiation Marker Suppression by Arsenic: Mediation by AP1 Response Elements and Antagonism by Tetradecanoylphorbol Acetate
18. Phenotypic Characterization of Targeted Knockdown of Cyclin-Dependent Kinases in the Intestinal Epithelial Cells.
19. Correction to: An IQ consortium analysis of starting dose selection for oncology small molecule first‑in‑patient trials suggests an alternative NOAEL‑based method can be safe while reducing time to the recommended phase 2 dose.
20. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
21. Validation of Cross-Species Reactivity of the VEGF-A/PDGFRβ Bifunctional Antibody PF-06653157.
22. Contribution of Membrane Trafficking Perturbation to Retinal Toxicity.
23. Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma.
24. Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits.
25. A tyrosine kinase inhibitor-induced myocardial degeneration in rats through off-target phosphodiesterase inhibition.
26. Retina Expression and Cross-Species Validation of Gene Silencing by PF-655, a Small Interfering RNA Against RTP801 for the Treatment of Ocular Disease.
27. Off-target immune cell toxicity caused by AG-012986, a pan-CDK inhibitor, is associated with inhibition of p38 MAPK phosphorylation.
28. Peripheral white blood cell toxicity induced by broad spectrum cyclin-dependent kinase inhibitors.
29. A distal region of the human TGM1 promoter is required for expression in transgenic mice and cultured keratinocytes.
30. Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts
31. The Contribution of Lysosomotropism to Autophagy Perturbation.
32. Lysosome Impairment, Phagocytosis Inhibition and Retinopathy.
33. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
34. Antisense inhibition of 11βhydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.